Table 1.

Patient characteristics and response to palliative radiotherapy for 27 sites in 10 patients.

Patient	Sex/age (y)	Pathology	Dose	Time since diagnosis (months)	Site	Size (cm)	Response	TLC (month)	Toxicity	Retreatment
1	f/78	FL(GIII)	8 Gy ×1	123	Chest wall	4	CR	13	None	None
			8 Gy ×1	124	Axillary	5	CR	12	None	None
2	m/69	MCL	8 Gy ×1	86	Nasal cavity	5	CR	4	None	None
3	m/70	MCL	8 Gy ×1	14	Abdominal wall	NA	CR	2	None	None
			8 Gy ×1	15	Neck	NA	Unknown	1	None	None
			8 Gy ×1	15	Abdominal wall	NA	Unknown	1	None	None
4	m/65	PTCL	8 Gy ×1	10	Neck	2	CR	1	None	None
			8 Gy ×1	10	Skin	NA	CR	1	None	None
5	m/38	DLBCL	4 Gy ×1	44	Hepatic hilar	4	NC	2	None	None
6	m/43	DLBCL	2 Gy ×1	84	Chest wall	4	PR	3	None	None
7	m/79	DLBCL	8 Gy ×1	9	Inguinal	1	PR	4	None	None
8	m/73	DLBCL	8 Gy ×1	9	Chest wall	NA	CR	5	None	None
			8 Gy ×1	9	Chest wall	NA	CR	5	None	None
9	f/66	DLBCL	8 Gy ×1	13	Skull base	NA	PR	2	None	None
			8 Gy ×1	13	Neck	6	PR	2	None	None
10	m/70	DLBCL	8 Gy ×1	46	Parotid	6	CR	4	None	4 months after
			8 Gy ×1	48	Face	3	PR	2	None	2 months AFTER
			8 Gy ×1	48	Mandibular	6	PR	2	a	2 months after
			8 Gy ×1	50	Arm	4	PR	4	None	None
			8 Gy ×1	50	Wrist	4	PR	4	None	None
			8 Gy ×1	50	Ankle	3	PR	4	None	None
			8 Gy ×1	51	Leg	2	CR	3	None	None
			8 Gy ×1	51	Chest wall	5	PR	3	None	None
			8 Gy ×1	52	Hip	7	PR	2	None	None
			8 Gy ×1	53	Leg	NA	PR	1	None	None
			8 Gy ×1	53	Leg	NA	Unknown	1	None	None
			6 Gy ×1	53	Hepatic hilar	6	PR	1	None	None
11	m/87	DLBCL	8 Gy ×1	46	Neck	3	CR	4	None	None
			8 Gy ×1	46	Axillary	4	CR	4	None	None
			8 Gy ×1	46	Inguinal	5	CR	3	None	None

Pathology: FL(GIII): follicular lymphoma (grade III), MCL: mantle cell lymphoma, DLBCL: diffuse large B-cell lymphoma, PTCL: peripheral T-cell lymphoma.

NA: not available TLC: time to local control.

^aTemporal acute gingivitis.